EU
Emory University Portfolio holdings
AUM
$27.7M
This Quarter Return
-13.78%
1 Year Return
+31.53%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$35.9M
AUM Growth
+$35.9M
(-51%)
Cap. Flow
-$27.1M
Cap. Flow
% of AUM
-75.49%
Top 10 Holdings %
Top 10 Hldgs %
65.11%
Holding
23
New
2
Increased
10
Reduced
8
Closed
3
Top Buys
| 1 |
BioCryst Pharmaceuticals
BCRX
|
$1.48M |
| 2 |
Televisa
TV
|
$1.21M |
| 3 |
NVTA
Invitae Corporation
NVTA
|
$497K |
| 4 |
Antero Resources
AR
|
$434K |
| 5 |
Kinder Morgan
KMI
|
$243K |
Top Sells
Sector Composition
| 1 | Healthcare | 26.68% |
| 2 | Financials | 8.11% |
| 3 | Consumer Discretionary | 7.73% |
| 4 | Communication Services | 7.19% |
| 5 | Energy | 6.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Vanguard FTSE Emerging Markets ETF
VWO
$96.4B
| $10.2M | 28.37% | 307,890 -750,891 | -71% | -$24.8M |
|
2
Viasat
VSAT
$4.34B
| $1.63M | 4.53% | 25,305 +1,231 | +5% | +$79.1K |
|
3
Incyte
INCY
$16.5B
| $1.58M | 4.39% | 14,287 +257 | +2% | +$28.4K |
|
4
Arch Capital
ACGL
$34.2B
| $1.51M | 4.21% | 20,551 -3,032 | -13% | -$223K |
|
|
5
BioCryst Pharmaceuticals
BCRX
$1.74B
| $1.48M | 4.11% | +129,415 | New | +$1.48M |
|
|
LVNTA
6
DELISTED
Liberty Interactive Corporation Series A Liberty Ventures
LVNTA
| $1.47M | 4.09% | 36,425 +1,560 | +4% | +$63K |
|
7
LPL Financial
LPLA
$29.2B
| $1.4M | 3.9% | 35,231 -964 | -3% | -$38.3K |
|
|
ESRX
8
DELISTED
Express Scripts Holding Company
ESRX
| $1.38M | 3.85% | 17,064 -48 | -0.3% | -$3.89K |
|
9
Liberty Media Series C
FWONK
$25B
| $1.37M | 3.83% | 39,882 +124 | +0.3% | +$4.27K |
|
10
Acadia Pharmaceuticals
ACAD
$4.38B
| $1.37M | 3.82% | 41,505 +2,094 | +5% | +$69.3K |
|
|
SGEN
11
DELISTED
Seagen Inc. Common Stock
SGEN
| $1.33M | 3.7% | 34,504 -3,113 | -8% | -$120K |
|
|
ANAC
12
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
| $1.31M | 3.64% | 11,096 -12,957 | -54% | -$1.53M |
|
|
WBC
13
DELISTED
WABCO HOLDINGS INC.
WBC
| $1.3M | 3.63% | 12,439 +821 | +7% | +$86.1K |
|
|
GHDX
14
DELISTED
Genomic Health, Inc.
GHDX
| $1.29M | 3.58% | 60,828 +5,862 | +11% | +$124K |
|
|
ALXN
15
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $1.27M | 3.53% | 8,101 -1,178 | -13% | -$184K |
|
|
NVTA
16
DELISTED
Invitae Corporation
NVTA
| $1.25M | 3.49% | 173,743 +68,882 | +66% | +$497K |
|
|
17
Kinder Morgan
KMI
$60B
| $1.22M | 3.4% | 44,064 +8,791 | +25% | +$243K |
|
|
18
Televisa
TV
$1.49B
| $1.21M | 3.36% | +46,388 | New | +$1.21M |
|
|
19
Antero Resources
AR
$9.86B
| $1.18M | 3.28% | 55,717 +20,514 | +58% | +$434K |
|
20
BioMarin Pharmaceuticals
BMRN
$11.2B
| $1.18M | 3.27% | 11,155 -1,012 | -8% | -$107K |
|
|
QVCGA
21
QVC Group, Inc. Series A Common Stock
QVCGA
$69.2M
| – | – | -52,924 | Closed | -$1.47M |
|
|
ONCE
22
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| – | – | -23,333 | Closed | -$1.41M |
|
|
DYAX
23
DELISTED
DYAX CORPORATION
DYAX
| – | – | -56,383 | Closed | -$1.49M |
|